| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/11/1996 | EP0747047A1 Combination of an antimicrobial compound (e.g. the lipoaminoacid N,n-octanoyl-glycine) and a monoalkylglycerol ether and its use as an antimicrobial agent |
| 12/11/1996 | EP0747043A1 Use of salicylic acid derivatives for skin whitening |
| 12/11/1996 | EP0747042A1 Compositions containing azole derivatives for topical application to skin |
| 12/11/1996 | EP0747040A1 Petroleum jelly with inositol phosphates |
| 12/11/1996 | EP0747033A1 Transfusion liquid-containing holder and prepared transfusion liquid |
| 12/11/1996 | EP0746619A1 Human phosphodiesterase type ivc, and its production and use |
| 12/11/1996 | EP0746564A1 4-n-substituted sialic acids and their sialosides |
| 12/11/1996 | EP0746559A1 Pyrrolo(2,3-d)pyrimidine derivatives as antivirals |
| 12/11/1996 | EP0746558A1 Phenylalkylamino derivatives of condensed carbapenemes |
| 12/11/1996 | EP0746557A1 Intracellular signalling mediators |
| 12/11/1996 | EP0746556A1 Tricyclic compounds having affinity for the 5-ht1a receptor |
| 12/11/1996 | EP0746554A1 4-heterocyclyl-substituted quinazoline derivatives, processes for their preparation and their use as anti-cancer agents |
| 12/11/1996 | EP0746551A1 Optically pure 4-aryl-2-hydroxytetronic acids |
| 12/11/1996 | EP0746549A1 Acetic acid amide derivatives and process for the preparation thereof |
| 12/11/1996 | EP0746547A1 2-(4-methoxyphenoxy)-3-pyridineamine, its preparation and its use as anti-inflammatory agent |
| 12/11/1996 | EP0746545A1 Nipecotic acid derivatives as antithrombic compounds |
| 12/11/1996 | EP0746544A1 Novel indole derivatives useful to treat estrogen-related neoplasms and disorders |
| 12/11/1996 | EP0746542A1 Therapeutic benzonitriles |
| 12/11/1996 | EP0746343A1 METHODS AND COMPOSITIONS OF A BIOARTIFICIAL KIDNEY SUITABLE FOR USE $i(IN VIVO) OR $i(EX VIVO) |
| 12/11/1996 | EP0746336A1 Prodrugs activated by targeted catalytic proteins |
| 12/11/1996 | EP0746332A1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
| 12/11/1996 | EP0746330A1 Airborne protectants against oxidative tissue damage |
| 12/11/1996 | EP0746328A1 Method and composition for treating psoriasis, seborrheic dermatitis and eczema |
| 12/11/1996 | EP0746326A1 Oligomeric compounds having nitrogen-containing linkages |
| 12/11/1996 | EP0746325A1 Liquid paraffin oil and lactulose-based hypocaloric laxative jelly and method for its preparation |
| 12/11/1996 | EP0746324A1 Method of combatting osteoporosis and other disease states in mammalian subjects, utilizing organic boron compounds |
| 12/11/1996 | EP0746323A1 Inhibitors of phosphoinositide-specific phospholipase c |
| 12/11/1996 | EP0746322A1 Treatment of alzheimer's disease and modulation of immune system with delta5-androstenes |
| 12/11/1996 | EP0746321A1 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
| 12/11/1996 | EP0746320A1 Hiv protease inhibitors and intermediates |
| 12/11/1996 | EP0746319A1 Acyclovir derivatives for topical use |
| 12/11/1996 | EP0746318A1 Injectable emulsions containing antifungal triazole derivatives |
| 12/11/1996 | EP0746317A1 Sublingual or buccal pharmaceutical composition |
| 12/11/1996 | EP0746316A1 Therapeutic guanidines |
| 12/11/1996 | EP0746315A1 Use of, and method of treatment using, carbazolyl-(4)-oxypropanolamine compounds for inhibition of smooth muscle cell proliferation |
| 12/11/1996 | EP0746314A1 Method of treating hyperproliferative vascular disease |
| 12/11/1996 | EP0746313A1 Method of treating small mouth ulcers |
| 12/11/1996 | EP0746312A1 Guanylhydrazones for treating inflammatory conditions |
| 12/11/1996 | EP0746305A1 Sunscreen compositions |
| 12/11/1996 | EP0746304A1 Retinoic acid as a skin tanning agent in persons of light skin color |
| 12/11/1996 | EP0746294A1 Absorption enhancers for topical pharmaceutical formulations |
| 12/11/1996 | EP0746265A1 In situ dissolution of alginate coatings of biological tissue transplants |
| 12/11/1996 | EP0746209A1 Improving growth and lactation of ruminants |
| 12/11/1996 | EP0746202A1 Pharmaceutically active antioxydant containing composition and the method of its use to prevent and treat restenosis following angioplasty |
| 12/11/1996 | EP0695305A4 Method of forming oligonucleotides |
| 12/11/1996 | EP0663906B1 Method of preparing taxane derivatives |
| 12/11/1996 | EP0655065B1 27-hydroxyrapamycin and derivatives thereof |
| 12/11/1996 | EP0644887B1 Intermediates in a process for the purification of clavulanic acid |
| 12/11/1996 | EP0642529B1 11beta-substituted 14,17-ethanoestratrienes, process for preparing these compounds and their use for preparing medicaments |
| 12/11/1996 | EP0635010B1 Novel cardioprotective agents |
| 12/11/1996 | EP0607163B1 NEUROLEPTIC 2-SUBSTITUTED PERHYDRO-1-H-PYRIDO[1,2-a]PYRAZINES |
| 12/11/1996 | EP0533840B1 Treatment of chronic renal failure with imidazole angiotensin-ii receptor antagonists |
| 12/11/1996 | EP0532512B1 Use of platelet activating factor antagonists as anti-pruritic agents |
| 12/11/1996 | EP0521080B1 Synergistic compositions |
| 12/11/1996 | EP0498890B1 Central nervous system activator |
| 12/11/1996 | CN1137799A Glucosamine disaccharides, method for their preparation pharmaceutical composition comprising same and their use |
| 12/11/1996 | CN1137797A Rapamycin derivatives useful as immunosuppressants |
| 12/11/1996 | CN1137796A Polycyclic antiparasitic agent, process and strain for their preparation and their use |
| 12/11/1996 | CN1137794A 5-(2-imidazolinylamino) benzimidazole derivatives, their preparation and their use as alpha-2 adrenoceptor agonists |
| 12/11/1996 | CN1137793A 6-(2-imidzolinylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists |
| 12/11/1996 | CN1137757A Compositions and methods for stimulating megakaryocyte growth and differentiation |
| 12/11/1996 | CN1137756A Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
| 12/11/1996 | CN1137755A 6-(2-imidazolinylamino) quinoxaling compounds useful as alpha-2 adrenoceptor agonists |
| 12/11/1996 | CN1137754A 7-(2-imidazolinylamino) quinoline compounds as alpha-2 adrenoceptor agonists |
| 12/11/1996 | CN1137753A Epibatidine and derivatives thereof as cholinergic receptor agonists and antagonists |
| 12/11/1996 | CN1137752A DI-tert-butylphenol compounds useful as anti-inflammatory agents |
| 12/11/1996 | CN1137751A Hydrophobic preparations |
| 12/11/1996 | CN1137568A Process for enzymatic synthesis of beta-lactam antibiotics in presence of enzyme inhibitor |
| 12/11/1996 | CN1137525A Naphthyl compounds, intermediates, compositions, and methods |
| 12/11/1996 | CN1137520A Substituded indole derivatives |
| 12/11/1996 | CN1137519A Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for production of pharmaceutical preparations, and pharmaceutical preparations containing them |
| 12/11/1996 | CN1137390A Oral liquor for curing pullorum disease |
| 12/11/1996 | CN1137380A Use of phenylcyclohexylcarboxamides |
| 12/11/1996 | CN1137379A Aebi bacterin sprinkling agent |
| 12/11/1996 | CN1137378A Use of HCPSH2 specific compounds to enhance erythropoiesis |
| 12/11/1996 | CN1033509C Process for preparation of water soluble camptothecin analogs |
| 12/10/1996 | US5583248 Amino acid derivatives having antiviral activity |
| 12/10/1996 | US5583242 Use of phosphotyrosine phosphatase inhibitors for controlling cellular proliferation |
| 12/10/1996 | US5583238 Method for making intermediates useful in synthesis of retroviral protease inhibitors |
| 12/10/1996 | US5583233 Retroviral protease inhibiting compounds |
| 12/10/1996 | US5583232 Treating human immunodeficiency virus infections |
| 12/10/1996 | US5583228 Reductase inhibitor; skin disorders |
| 12/10/1996 | US5583226 Chemical intermediates of viricidal nucleotides |
| 12/10/1996 | US5583224 Isolation and elucidation of cephalostatin 7, 8 and 9 |
| 12/10/1996 | US5583222 Antiinflammatory agents for treatment of skin disorders |
| 12/10/1996 | US5583221 Antiinflammatory agents, cardiovascular disorders, viricides, fungicides |
| 12/10/1996 | US5583220 Pyrole nitrogen-substituted texaphyrins |
| 12/10/1996 | US5583208 Ganglioside GM3 derivatives containing fluorine in ceramide portion |
| 12/10/1996 | US5583206 Chelating polymers |
| 12/10/1996 | US5583160 Exposing cells to dimethyl sphingosine until preferential level of cell death has occured |
| 12/10/1996 | US5583159 Treatment of internal radiation damage |
| 12/10/1996 | US5583156 An oxycarboxylic compound |
| 12/10/1996 | US5583155 Viricides; potentiation |
| 12/10/1996 | US5583153 Administering taxol solubilized in carrier to suppress symptoms of progressive inflammatory autoimmune arthritis in mammals |
| 12/10/1996 | US5583152 Method for treating vasospastic cardiovascular diseases heterocyclic amide derivatives |
| 12/10/1996 | US5583150 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic anilides for the treatment of ocular diseases |
| 12/10/1996 | US5583149 Treating vascular headaches |
| 12/10/1996 | US5583148 Bis-acyloxymethyl derivatives |
| 12/10/1996 | US5583145 Psychological disorders |
| 12/10/1996 | US5583144 Methods for treating erectile impotence |